Pulmatrix, Inc.
General ticker "PULM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $22.7M (TTM average)
Pulmatrix, Inc. does not follow the US Stock Market performance with the rate: -31.4%.
Estimated limits based on current volatility of 4.9%: low 1.93$, high 2.22$
Factors to consider:
- Total employees count: 22 (-24.1%) as of 2023
- Top business risk factors: Net losses, Capital raising, Economic downturns and volatility, Labor/talent shortage/retention, Product candidate success
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.23$, 3.86$]
- 2026-12-31 to 2027-12-31 estimated range: [0.82$, 2.61$]
Financial Metrics affecting the PULM estimates:
- Positive: with PPE of -1.9 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -56.71 <= 0.01
- Positive: Shareholder equity ratio, % of 92.05 > 64.29
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 0 > -0.63
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Inventory ratio change, % of 0 <= 0
Short-term PULM quotes
Long-term PULM plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $7.30MM | $5.19MM | $0.00MM |
| Operating Expenses | $22.04MM | $14.95MM | $5.17MM |
| Operating Income | $-14.74MM | $-9.76MM | $-5.17MM |
| Non-Operating Income | $0.62MM | $0.20MM | $0.01MM |
| R&D Expense | $15.52MM | $7.17MM | $0.04MM |
| Income(Loss) | $-14.12MM | $-9.56MM | $-5.16MM |
| Profit(Loss)* | $-14.12MM | $-9.56MM | $-5.16MM |
| Stockholders Equity | $18.00MM | $8.95MM | $3.81MM |
| Assets | $33.96MM | $9.94MM | $4.14MM |
| Operating Cash Flow | $-15.98MM | $-10.72MM | $-5.43MM |
| Capital expenditure | $0.68MM | $0.40MM | $0.00MM |
| Investing Cash Flow | $-0.68MM | $-0.40MM | $0.00MM |
| Financing Cash Flow | $0.05MM | $0.00MM | $0.00MM |
| Earnings Per Share** | $-3.87 | $-2.62 | $-1.41 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.